Harold I. Saavedra
Research Subjects
Harold I. Saavedra has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Abigail E. Lantz
University of South Florida Morsani College of Medicine, Tampa, FL
32 shared publications - Allison Bahr
Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
32 shared publications - Dung-Tsa Chen
Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
32 shared publications - Edna R. Gordián
Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
32 shared publications - Idhaliz Flores
Department of Basic Sciences, Ponce Research Institute, Ponce Health Sciences University, Ponce, Puerto Rico
32 shared publications - Jiannong Li
Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida
32 shared publications
Latest Publications
- Open Access
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Table S19 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 19: Summary of number of PR-stained cores per patient (by cohort).
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S19 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 19: Summary of number of PR-stained cores per patient (by cohort).
- Open Access
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Table S7 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 7: Comparison of Clinical ER calls vs. TMA stain evaluations (simplified).
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S7 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 7: Comparison of Clinical ER calls vs. TMA stain evaluations (simplified).
- Open Access
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Table S6 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 6: Analysis of all IHC scoring values of the 371 tumor cores on the TMA by cohort.
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 6: Analysis of all IHC scoring values of the 371 tumor cores on the TMA by cohort.
- Open Access
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Table S8 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 8: Comparison of Clinical PR calls vs. TMA stain evaluations.
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 8: Comparison of Clinical PR calls vs. TMA stain evaluations.
- Open Access
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Figure 5 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
PAM50 analysis shows that basal-like subtype is most frequent among NHBs. Stacked bar chart shows the results of PAM50 gene expression analysis on patients represented on the ME-BrTMA with available RNA sequencing data. The data show that the basal-like subtype is most frequent among NHBs represented on the TMA (P = 0.031). Supplementary Table S15 tabulates the PAM50 subgroup breakdown by cohort. Note that RNA sequencing data for the NHW patients in cohort 1 are not included because they are not available.
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 5 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
PAM50 analysis shows that basal-like subtype is most frequent among NHBs. Stacked bar chart shows the results of PAM50 gene expression analysis on patients represented on the ME-BrTMA with available RNA sequencing data. The data show that the basal-like subtype is most frequent among NHBs represented on the TMA (P = 0.031). Supplementary Table S15 tabulates the PAM50 subgroup breakdown by cohort. Note that RNA sequencing data for the NHW patients in cohort 1 are not included because they are not available.
- Open Access
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Table S11 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 11: Summary of HR/HER2 stain evaluation by cohort.
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S11 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 11: Summary of HR/HER2 stain evaluation by cohort.
- Open Access
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Table S21 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 21: Summary of number of HER2-stained cores per patient (by cohort).
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S21 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 21: Summary of number of HER2-stained cores per patient (by cohort).
- Open Access
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 3: Summary of all 610 cores of the TMA.
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 3: Summary of all 610 cores of the TMA.
- Open Access
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 2: Outcomes for ME-BRTMA by cohort.
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Supplementary Table 2: Outcomes for ME-BRTMA by cohort.
- Open Access
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Data from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Breast cancer is a leading cause of cancer-related mortality among women worldwide and is known to have higher mortality among women with African ancestry. Herein, we describe the creation and characterization of a multiethnic breast cancer tissue microarray (ME-BrTMA) representing tumors from non-Hispanic White (n = 41), non-Hispanic Black (NHB; n = 45), and Hispanic patients from Puerto Rico (n = 36) and Florida (n = 52). This ME-BrTMA comprises five blocks with a total of 610 cores: 371 breast cancer tumor cores, 93 breast stromal cores, 96 normal breast tissue cores, 30 non–breast cancer tumor cores, and 20 cores representing normal tissues. Initial characterization of the ME-BrTMA includes standard IHC staining of well-characterized clinical biomarkers, including the estrogen hormone receptors and progesterone hormone receptors, HER2, and Ki-67, interpreted by the coauthoring pathologist (Marilin Rosa). The IHC results indicated good but imperfect alignment with clinical diagnoses. Cores from breast cancer tumors from the NHB cohort most frequently scored negative for estrogen receptor (63%, P < 0.005) and progesterone receptor (80%, P < 0.005) and most frequently have high expression of the Ki-67 proliferation marker (38%, P < 0.05). Prediction Analysis of Microarray 50 (PAM50) analysis using RNA from secondary patient blocks showed that the NHB group also most frequently scored in the basal-like category (61%, P < 0.05). Taken together, the initial characterization of the ME-BrTMA suggests that it may serve as a representative resource to understand the underlying biology of breast cancer and its relationship to patient outcomes.Significance:The ME-BrTMA described herein provides a resource that may serve as a tool to understand the underlying biology of breast cancer.
- 16 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Breast cancer is a leading cause of cancer-related mortality among women worldwide and is known to have higher mortality among women with African ancestry. Herein, we describe the creation and characterization of a multiethnic breast cancer tissue microarray (ME-BrTMA) representing tumors from non-Hispanic White (n = 41), non-Hispanic Black (NHB; n = 45), and Hispanic patients from Puerto Rico (n = 36) and Florida (n = 52). This ME-BrTMA comprises five blocks with a total of 610 cores: 371 breast cancer tumor cores, 93 breast stromal cores, 96 normal breast tissue cores, 30 non–breast cancer tumor cores, and 20 cores representing normal tissues. Initial characterization of the ME-BrTMA includes standard IHC staining of well-characterized clinical biomarkers, including the estrogen hormone receptors and progesterone hormone receptors, HER2, and Ki-67, interpreted by the coauthoring pathologist (Marilin Rosa). The IHC results indicated good but imperfect alignment with clinical diagnoses. Cores from breast cancer tumors from the NHB cohort most frequently scored negative for estrogen receptor (63%, P < 0.005) and progesterone receptor (80%, P < 0.005) and most frequently have high expression of the Ki-67 proliferation marker (38%, P < 0.05). Prediction Analysis of Microarray 50 (PAM50) analysis using RNA from secondary patient blocks showed that the NHB group also most frequently scored in the basal-like category (61%, P < 0.05). Taken together, the initial characterization of the ME-BrTMA suggests that it may serve as a representative resource to understand the underlying biology of breast cancer and its relationship to patient outcomes.Significance:The ME-BrTMA described herein provides a resource that may serve as a tool to understand the underlying biology of breast cancer.